Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Aug;60(2):206–210. doi: 10.1038/bjc.1989.252

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia.

J M Sargent 1, C G Taylor 1
PMCID: PMC2247032  PMID: 2765367

Abstract

We describe the application of a simple, rapid, semi-automated assay to the sensitivity testing of cytotoxic drugs in 23 patients with acute myeloid leukaemia (AML). The survival of blast cells from the bone marrow was measured by the MTT assay after 48 h continuous exposure to drugs both singly and in combination. There was a linear relationship between the number of leukaemic cells and the optical density of the formazan produced. The assay demonstrated a variation in drug sensitivity between patients. The technique was reproducible and there was no significant difference in response between blast cells obtained from bone marrow or from peripheral blood. Preliminary results show a correlation between in vitro and in vivo data. The test can be repeated throughout the course of the disease to help identify any change in tumour sensitivity. This technique appears to give useful information to assist in the management of acute myeloid leukaemia.

Full text

PDF
208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alley M. C., Scudiero D. A., Monks A., Hursey M. L., Czerwinski M. J., Fine D. L., Abbott B. J., Mayo J. G., Shoemaker R. H., Boyd M. R. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988 Feb 1;48(3):589–601. [PubMed] [Google Scholar]
  2. Bird M. C., Bosanquet A. G., Forskitt S., Gilby E. D. Long-term comparison of results of a drug sensitivity assay in vitro with patient response in lymphatic neoplasms. Cancer. 1988 Mar 15;61(6):1104–1109. doi: 10.1002/1097-0142(19880315)61:6<1104::aid-cncr2820610609>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  3. Bird M. C., Forskitt S., Gilby E. D., Bosanquet A. G. The influence of sample source and cell concentration on the in vitro chemosensitivity of haematological tumours. Br J Cancer. 1986 Apr;53(4):539–545. doi: 10.1038/bjc.1986.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987 Feb 15;47(4):936–942. [PubMed] [Google Scholar]
  5. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986 May 22;89(2):271–277. doi: 10.1016/0022-1759(86)90368-6. [DOI] [PubMed] [Google Scholar]
  6. Marie J. P., Zittoun R., Delmer A., Thevenin D., Suberville A. M. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia. Leukemia. 1987 Feb;1(2):121–126. [PubMed] [Google Scholar]
  7. Pieters R., Huismans D. R., Leyva A., Veerman A. J. Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. Cancer Lett. 1988 Aug 30;41(3):323–332. doi: 10.1016/0304-3835(88)90294-7. [DOI] [PubMed] [Google Scholar]
  8. Raza A., Maheshwari Y., Mandava N., Yasin Z., Perveen S., Mayers G., Browman G., Goldberg J., Gottlieb A., Grunwald H. Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia. Semin Oncol. 1987 Jun;14(2 Suppl 1):217–225. [PubMed] [Google Scholar]
  9. Rees J. K., Gray R. G., Swirsky D., Hayhoe F. G. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet. 1986 Nov 29;2(8518):1236–1241. doi: 10.1016/s0140-6736(86)92674-7. [DOI] [PubMed] [Google Scholar]
  10. Schwarzmeier J. D., Paietta E., Mittermayer K., Pirker R. Prediction of the response to chemotherapy in acute leukemia by a short-term test in vitro. Cancer. 1984 Feb 1;53(3):390–395. doi: 10.1002/1097-0142(19840201)53:3<390::aid-cncr2820530304>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  11. Selby P., Bizzari J. P., Buick R. N. Therapeutic implications of a stem cell model for human breast cancer: a hypothesis. Cancer Treat Rep. 1983 Jul-Aug;67(7-8):659–663. [PubMed] [Google Scholar]
  12. Twentyman P. R., Fox N. E., Rees J. K. Chemosensitivity testing of fresh leukaemia cells using the MTT colorimetric assay. Br J Haematol. 1989 Jan;71(1):19–24. doi: 10.1111/j.1365-2141.1989.tb06268.x. [DOI] [PubMed] [Google Scholar]
  13. Twentyman P. R., Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer. 1987 Sep;56(3):279–285. doi: 10.1038/bjc.1987.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weisenthal L. M., Dill P. L., Finklestein J. Z., Duarte T. E., Baker J. A., Moran E. M. Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat Rep. 1986 Nov;70(11):1283–1295. [PubMed] [Google Scholar]
  15. Weisenthal L. M., Dill P. L., Kurnick N. B., Lippman M. E. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res. 1983 Jan;43(1):258–264. [PubMed] [Google Scholar]
  16. Weisenthal L. M., Lippman M. E. Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep. 1985 Jun;69(6):615–632. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES